ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
105 hedge funds and large institutions have $197M invested in Antares Pharma, Inc. in 2018 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
105
Holders Change
+4
Holders Change %
+3.96%
% of All Funds
2.4%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
16
Increased
33
Reduced
29
Closed
12
Calls
$465K
Puts
$617K
Net Calls
-$152K
Net Calls Change
-$446K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$12.5M |
| 2 |
2
Millennium Management
New York
|
$2.32M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$3.16M |
| 4 |
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$1.82M |
| 5 |
5
Two Sigma Investments
New York
|
$882K |
